GnRH antagonists are safer than agonists: An update of a Cochrane review

Human Reproduction Update

Volumn 17, Issue 4, 2011, Pages 435-

  Al Inany, Hesham G ^a   Youssef, Mohamed M A F M ^a   Aboulghar, Mohamed ^a   Broekmans, Frank ^b   Sterrenburg, Monique ^b   Smit, Janine ^b   Abou Setta, Ahmed M ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GONADORELIN ANTAGONIST;

ARTICLE; CLINICAL TRIAL; DRUG SAFETY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REPRODUCTION; UNSPECIFIED SIDE EFFECT;

FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INCIDENCE; LIVE BIRTH; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS;

EID: 79958725781     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmr004     Document Type: Article

References (3)

1. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2006;3:CD001750.
2. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG (eds). Systematic Reviews in Health Care: Meta-analysis in Context, 2nd edn. London: BMJ Publishing Group, 2001, 285-312.
3. Youssef MAFM, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, Khattab SM, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD008046. DOI:10.1002/14651858.CD008046.pub3.